Related Experiment Video
Updated: May 29, 2026
04:42
Developing a Rat Model for Bipolar Disorder
Published on: May 2, 2025
New drugs for bipolar disorder.
Marsal Sanches1, Jair C Soares
1University of Texas Center of Excellence on Mood Disorders, Department of Psychiatry and Behavioral Sciences, The University of Texas Medical School at Houston, 1541 East Road, Houston, TX 77054, USA. marsal.sanches@uth.tmc.edu
Current Psychiatry Reports
|August 31, 2011
Summary
New pharmacologic treatments offer hope for bipolar disorder (BD) patients, particularly for residual symptoms and cognitive issues. While core treatments remain stable, augmentation strategies show promise for improved remission rates in bipolar disorder.
Area of Science:
- Psychiatry and Pharmacology
- Neuroscience
- Mental Health Research
Background:
- Bipolar disorder (BD) is a severe mental illness with significant treatment challenges.
- Current therapies often result in incomplete remission, leading to persistent symptoms and functional impairment.
- There is a critical need for novel therapeutic approaches to improve outcomes for BD patients.
Purpose of the Study:
- To conduct a comprehensive review of emerging pharmacologic treatments for bipolar disorder.
- To identify promising new augmentation strategies for existing BD therapies.
- To explore advancements in treating bipolar depression and BD-related cognitive deficits.
Main Methods:
- Systematic literature review of recent pharmacologic research in bipolar disorder.
- Analysis of clinical trial data and preclinical studies on novel drug candidates.
- Evaluation of treatment efficacy and safety profiles for new therapeutic agents.
Main Results:
- Several promising new augmentation strategies for bipolar disorder were identified.
- Emerging treatments show potential for addressing residual symptoms and improving patient remission rates.
- Research into novel therapies for bipolar depression and cognitive impairment in BD is particularly active.
Conclusions:
- While foundational bipolar disorder treatments are expected to remain consistent, new augmentation strategies offer significant therapeutic potential.
- Future research directions should focus on developing targeted treatments for bipolar depression and cognitive dysfunction.
- These advancements hold promise for enhancing the long-term management and quality of life for individuals with bipolar disorder.
Related Concept Videos
01:24Mania and Antimanic Drugs: Overview
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as a...
01:23Antidepressant Drugs: MAOIs and Other Agents
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
01:28Drug Therapy
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
01:25Antidepressant Drugs: Overview
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
01:28Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
01:26Psychosis: Goals of Pharmacotherapy
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation. For...